You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Lopinavir/ritonavir (LPV/r)

Showing 1 - 25 of 3,550
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tuberculosis Trial in United States (PA-824, Efavirenz (EFV), Lopinavir/Ritonavir (LPV/r))

Completed
  • Tuberculosis
  • San Francisco, California
  • +3 more
Nov 4, 2021

COVID-19 Trial in France (Hydroxychloroquine, Placebo of Hydroxychloroquine, Lopinavir and ritonavir)

Terminated
  • COVID-19
  • Angers, France
  • +8 more
Oct 3, 2022

Fixed Dose Combination of Lopinavir/Ritonavir in Human

Terminated
  • HIV-1 Infection
    • Kazan, Tatarstan, Respublika, Russian Federation
    • +9 more
    Jul 1, 2021

    HIV Infection Trial in United States (Different formulations of once-daily lopinavir/ritonavir)

    Completed
    • HIV Infection
    • Different formulations of once-daily lopinavir/ritonavir
    • Irvine, California
    • +4 more
    Jun 25, 2020

    HIV, AIDS Trial in China (albuvirtide, lopinavir-ritonavir, tenofovir)

    Completed
    • HIV Infections
    • AIDS
    • Beijing, Beijing, China
    • +11 more
    Sep 28, 2021

    HIV/AIDS and Infections Trial in China (Zidovudine, Nevirapine, Lamivudine)

    Completed
    • HIV/AIDS and Infections
    • Guangzhou, Guangdong, China
    • +4 more
    Sep 27, 2022

    HIV Positive, Malnourished Trial in Worldwide (ZDV+3TC+LPV/r)

    Completed
    Has Results
    • HIV Positive
    • Malnourished
    • Blantyre, Malawi
    • +4 more
    Jul 19, 2021

    HIV Trial in United States (Kaletra + Isentress, Atripla)

    Completed
    Has Results
    • HIV Infections
    • Long Beach, California
    • +5 more
    Jul 13, 2020

    HIV Trial in Worldwide (Lopinavir/ritonavir)

    Completed
    Has Results
    • HIV
    • La Jolla, California
    • +18 more
    Nov 3, 2021

    HIV-1 Infection Trial in Worldwide (Lopinavir/ritonavir, Raltegravir, Emtricitabine/tenofovir disoproxil fumarate)

    Completed
    Has Results
    • HIV-1 Infection
    • Rio de Janeiro, Brazil
    • +15 more
    Aug 3, 2021

    HIV Trial (Abacavir sulfate, Didanosine, Efavirenz)

    Completed
    Has Results
    • HIV Infections
    • Abacavir sulfate
    • +6 more
    • (no location specified)
    Oct 29, 2021

    COVID-19 Trial in London (Favipiravir, Lopinavir/ Ritonavir, Favipiravir Placebo)

    Completed
    • COVID-19
    • London, United Kingdom
    • +1 more
    Dec 12, 2022

    HIV-1 Infections Trial in Bangkok (Generic LPV/r and Aluvia (pharmacokinetics), Aluvia and Generic LPV/r (pharmacokinetics))

    Completed
    • HIV-1 Infections
    • Generic LPV/r and Aluvia (pharmacokinetics)
    • Aluvia and Generic LPV/r (pharmacokinetics)
    • Bangkok, Thailand
      HIV-NAT, Thai Red Cross AIDS Research Centre
    Jul 15, 2020

    Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

    Withdrawn
    • Hodgkin Lymphoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 28, 2022

    HIV, Tuberculosis Trial in Bangkok (LPV/r)

    Completed
    • HIV Infections
    • Tuberculosis
    • Bangkok, Thailand
      HIV-NAT Thai Red Cross AIDS Research Center
    Jul 15, 2020

    Simplified Treatment of Anti-retrovirus in China (C-STAR)

    Recruiting
    • HIV/AIDS
    • Guangzhou, Guangdong, China
      Guangzhou 8th People's Hospital
    Jul 19, 2021

    COVID-19, COVID-19 Drug Treatment, Severe Acute Respiratory Syndrome Coronavirus 2 Trial in Abidjan (Lopinavir/Ritonavir 200

    Recruiting
    • COVID-19
    • +2 more
    • Lopinavir/Ritonavir 200 MG-50 MG Oral Tablet
    • +2 more
    • Abidjan, Côte D'Ivoire
    • +1 more
    Feb 3, 2021

    Drug-Drug Interaction, HIV Infection Trial in Masafu, Kampala (Dihydroartemisinin-piperaquine)

    Completed
    • Drug-Drug Interaction
    • HIV Infection
    • Masafu, Busia, Uganda
    • +1 more
    May 18, 2022

    HIV/AIDS Trial in Yaounde (Darunavir, ART with 2 NRTIs plus LPV/r (or ATV/r))

    Completed
    Has Results
    • HIV/AIDS
    • Darunavir
    • ART with 2 NRTIs plus LPV/r (or ATV/r)
    • Yaounde, Centre, Cameroon
      Yaounde Central Hospital
    Aug 30, 2019

    HIV Trial in Johannesburg (Nevirapine, Zidovudine, Lamivudine)

    Completed
    • HIV
    • Johannesburg, Gauteng, South Africa
      Rahima Moosa Mother and Child Hospital
    Jul 31, 2020

    Tuberculosis, HIV Trial (Dolutegravir, 3HP)

    Not yet recruiting
    • Tuberculosis
    • HIV
    • (no location specified)
    Dec 9, 2022

    HIV Trial in Worldwide (DTG, LPV/RTV, Two NRTIs)

    Completed
    Has Results
    • HIV Infections
    • Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
    • +58 more
    Feb 23, 2022

    Coronavirus Infections, Post-exposure Prophylaxis Trial in Vancouver, Toronto (Lopinavir/ritonavir)

    Active, not recruiting
    • Coronavirus Infections
    • Post-exposure Prophylaxis
    • Vancouver, British Columbia, Canada
    • +3 more
    Nov 29, 2021

    HIV Trial in Brazil, Puerto Rico, United States (Lopinavir/Ritonavir)

    Completed
    • HIV Infections
    • Oakland, California
    • +16 more
    Oct 28, 2021

    HIV Infection Trial in Worldwide (Nucleoside Reverse Transcriptase Inhibitors (NRTIs), Nevirapine (NVP), Lopinavir/Ritonavir

    Recruiting
    • HIV Infection
    • Nucleoside Reverse Transcriptase Inhibitors (NRTIs)
    • +4 more
    • La Jolla, California
    • +46 more
    Nov 3, 2021